These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 37563620)

  • 41. IL-17 production from activated T cells is required for the spontaneous development of destructive arthritis in mice deficient in IL-1 receptor antagonist.
    Nakae S; Saijo S; Horai R; Sudo K; Mori S; Iwakura Y
    Proc Natl Acad Sci U S A; 2003 May; 100(10):5986-90. PubMed ID: 12721360
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Th1 and Th2 cytokines IFN-gamma and IL-4 antagonize the inhibition of monocyte IL-1 receptor antagonist by glucocorticoids: involvement of IL-1.
    Kovalovsky D; Páez Pereda M; Sauer J; Perez Castro C; Nahmod VE; Stalla GK; Holsboer F; Arzt E
    Eur J Immunol; 1998 Jul; 28(7):2075-85. PubMed ID: 9692875
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ex vivo culture with interleukin (IL)-12 improves CD8(+) T-cell adoptive immunotherapy for murine leukemia independent of IL-18 or IFN-gamma but requires perforin.
    Macgregor JN; Li Q; Chang AE; Braun TM; Hughes DP; McDonagh KT
    Cancer Res; 2006 May; 66(9):4913-21. PubMed ID: 16651448
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Interferon gamma inhibits CXCL8-CXCR2 axis mediated tumor-associated macrophages tumor trafficking and enhances anti-PD1 efficacy in pancreatic cancer.
    Zhang M; Huang L; Ding G; Huang H; Cao G; Sun X; Lou N; Wei Q; Shen T; Xu X; Cao L; Yan Q
    J Immunother Cancer; 2020 Feb; 8(1):. PubMed ID: 32051287
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibition of interleukin-6 signaling attenuates aortitis, left ventricular hypertrophy and arthritis in interleukin-1 receptor antagonist deficient mice.
    Hada Y; Uchida HA; Mukai T; Kojima F; Yoshida M; Takeuchi H; Kakio Y; Otaka N; Morita Y; Wada J
    Clin Sci (Lond); 2020 Oct; 134(20):2771-2787. PubMed ID: 33064141
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of interleukin 1 receptor antagonist gene transduction on human melanoma xenografts in nude mice.
    Weinreich DM; Elaraj DM; Puhlmann M; Hewitt SM; Carroll NM; Feldman ED; Turner EM; Spiess PJ; Alexander HR
    Cancer Res; 2003 Sep; 63(18):5957-61. PubMed ID: 14522922
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interleukin-1 alpha increases anti-tumor efficacy of cetuximab in head and neck squamous cell carcinoma.
    Espinosa-Cotton M; Rodman Iii SN; Ross KA; Jensen IJ; Sangodeyi-Miller K; McLaren AJ; Dahl RA; Gibson-Corley KN; Koch AT; Fu YX; Badovinac VP; Laux D; Narasimhan B; Simons AL
    J Immunother Cancer; 2019 Mar; 7(1):79. PubMed ID: 30890189
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Extracellular release of the type I intracellular IL-1 receptor antagonist from human airway epithelial cells: differential effects of IL-4, IL-13, IFN-gamma, and corticosteroids.
    Levine SJ; Wu T; Shelhamer JH
    J Immunol; 1997 Jun; 158(12):5949-57. PubMed ID: 9190949
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Decreased mortality of severe acute pancreatitis after proximal cytokine blockade.
    Norman JG; Franz MG; Fink GS; Messina J; Fabri PJ; Gower WR; Carey LC
    Ann Surg; 1995 Jun; 221(6):625-31; discussion 631-4. PubMed ID: 7794067
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pancreatic ductal adenocarcinoma contains an effector and regulatory immune cell infiltrate that is altered by multimodal neoadjuvant treatment.
    Shibuya KC; Goel VK; Xiong W; Sham JG; Pollack SM; Leahy AM; Whiting SH; Yeh MM; Yee C; Riddell SR; Pillarisetty VG
    PLoS One; 2014; 9(5):e96565. PubMed ID: 24794217
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Oral squamous cell carcinoma-derived EVs promote tumor progression by regulating inflammatory cytokines and the IL-17A-induced signaling pathway.
    Li R; Zhou Y; Zhang M; Xie R; Duan N; Liu H; Qin Y; Ma J; Li Z; Ye P; Wang W; Wang X
    Int Immunopharmacol; 2023 May; 118():110094. PubMed ID: 37030119
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The multifaceted effects of polysaccharides isolated from Dendrobium huoshanense on immune functions with the induction of interleukin-1 receptor antagonist (IL-1ra) in monocytes.
    Lin J; Chang YJ; Yang WB; Yu AL; Wong CH
    PLoS One; 2014; 9(4):e94040. PubMed ID: 24705413
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Matrilin-3 induction of IL-1 receptor antagonist is required for up-regulating collagen II and aggrecan and down-regulating ADAMTS-5 gene expression.
    Jayasuriya CT; Goldring MB; Terek R; Chen Q
    Arthritis Res Ther; 2012 Sep; 14(5):R197. PubMed ID: 22967398
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of cytokine levels in response to mitogen among HIV-1-infected blood cells and their relationships to the number of T cells.
    Imoto S; Suzukawa M; Takeda K; Asari I; Watanabe S; Tohma S; Nagase T; Ohta K; Teruya K; Nagai H
    Cytokine; 2022 May; 153():155840. PubMed ID: 35276635
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Enhanced Th1 and Th17 responses and arthritis severity in mice with a deficiency of myeloid cell-specific interleukin-1 receptor antagonist.
    Lamacchia C; Palmer G; Seemayer CA; Talabot-Ayer D; Gabay C
    Arthritis Rheum; 2010 Feb; 62(2):452-62. PubMed ID: 20112392
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Combining the Specific Anti-MUC1 Antibody TAB004 and Lip-MSA-IL-2 Limits Pancreatic Cancer Progression in Immune Competent Murine Models of Pancreatic Ductal Adenocarcinoma.
    Dréau D; Moore LJ; Wu M; Roy LD; Dillion L; Porter T; Puri R; Momin N; Wittrup KD; Mukherjee P
    Front Oncol; 2019; 9():330. PubMed ID: 31114758
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interleukin-1 receptor antagonist gene (
    Attur M; Petrilli C; Adhikari S; Iturrate E; Li X; Tuminello S; Hu N; Chakravarti A; Beck D; Abramson SB
    medRxiv; 2023 Jan; ():. PubMed ID: 36711766
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of interleukin-1 receptor signaling in the behavioral effects of ethanol and benzodiazepines.
    Blednov YA; Benavidez JM; Black M; Mayfield J; Harris RA
    Neuropharmacology; 2015 Aug; 95():309-20. PubMed ID: 25839897
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pyrin Inflammasome Activation Abrogates Interleukin-1 Receptor Antagonist, Suggesting a New Mechanism Underlying Familial Mediterranean Fever Pathogenesis.
    Mortensen SB; Hansen AE; Mogensen TH; Jakobsen MA; Beck HC; Harvald EB; Lambertsen KL; Johansen IS; Andersen DC
    Arthritis Rheumatol; 2021 Nov; 73(11):2116-2126. PubMed ID: 33913256
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interleukin-35 has a tumor-promoting role in hepatocellular carcinoma.
    Liu X; Ren H; Guo H; Wang W; Zhao N
    Clin Exp Immunol; 2021 Feb; 203(2):219-229. PubMed ID: 33030251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.